Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less complex and less ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

UnitedHealth's high medical costs and lower-than-expected revenue in the fourth quarter underscored persistent challenges at ...

The U.S. on Wednesday banned the use of a synthetic food dye that gives some candies, cakes and certain oral medications a ...

UnitedHealth Group reported fourth-quarter revenue below Wall Street estimates on Thursday, hurt by weakness in its health ...

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree in International Journalism from City, University of London.

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...

UnitedHealth Group reported a fourth-quarter profit on Thursday that beat analysts' estimates due to strength in its health ...